HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergency department awareness of heparin-induced thrombocytopenia: how frequently is risk assessment documented in patients with thrombosis?

Abstract
Evidence-based guidelines recommend that heparin-induced thrombocytopenia (HIT) should be suspected whenever a patient develops thrombosis or thrombocytopenia 5 to 14 days after heparin initiation. The authors determined how frequently emergency department (ED) physicians document HIT risk assessment in patients presenting with thrombosis. Relevant data were extracted from the ED charts of 134 patients with venous or arterial thrombosis. Documentation (ie, notation of positive or negative findings) existed for recent heparin exposure in 7 (5.2%) of 134 charts, recent hospitalization in 33 (24.6%), history of thrombocytopenia in 0 (0%), and history of thrombosis in 62 (45.5%). Of 35 patients administered heparin in the ED, the preheparin platelet count was available for 19 (54.3%) and old records for 5 (14.3%). Thus, HIT risk assessment frequently remains undocumented for ED patients with thrombosis, including those administered heparin. Approaches to increase HIT awareness and facilitate HIT risk assessment and documentation in the ED may be needed.
AuthorsRobert L Levine, Robert Funk, Georgene W Hergenroeder, Marcie J Hursting
JournalAmerican journal of medical quality : the official journal of the American College of Medical Quality (Am J Med Qual) 2010 Sep-Oct Vol. 25 Issue 5 Pg. 365-9 ISSN: 1555-824X [Electronic] Netherlands
PMID20522721 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Heparin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants (adverse effects)
  • Emergency Service, Hospital
  • Female
  • Heparin (adverse effects)
  • Humans
  • Male
  • Medical Audit
  • Middle Aged
  • Retrospective Studies
  • Risk Assessment (statistics & numerical data)
  • Risk Management (statistics & numerical data)
  • Thrombocytopenia (chemically induced, prevention & control)
  • Thrombosis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: